News Releases News Releases Year None20212020201920182016 Sep, 29 2021 TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation Sep, 7 2021 TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S. Aug, 26 2021 TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference Aug, 9 2021 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Aug, 5 2021 TransMedics Reports Second Quarter 2021 Financial Results Jul, 29 2021 TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs Jul, 28 2021 TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference Jul, 22 2021 TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021 Jul, 14 2021 TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System Jul, 14 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 21
News Releases Year None20212020201920182016 Sep, 29 2021 TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation Sep, 7 2021 TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S. Aug, 26 2021 TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference Aug, 9 2021 TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Aug, 5 2021 TransMedics Reports Second Quarter 2021 Financial Results Jul, 29 2021 TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs Jul, 28 2021 TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference Jul, 22 2021 TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021 Jul, 14 2021 TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System Jul, 14 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 21
Sep, 29 2021 TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation
Sep, 7 2021 TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.
Aug, 26 2021 TransMedics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Jul, 14 2021 TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System
